1. Could nerve growth factor inhibitors have a place in the treatment of knee osteoarthritis?: Impact of joint destruction and means of administration ossn the value of Tanezumabs. (April 2015) Authors: Losina, E.; Michl, G.; Collins, J.; Hunter, D.J.; Jordan, J.M.; Yelin, E.; Paltiel, A.D.; Katz, J.N. Journal: Osteoarthritis and cartilage Issue: Volume 23(2015)Supplement 2 Page Start: A394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration. Issue 5 (May 2016) Authors: Losina, E.; Michl, G.; Collins, J.E.; Hunter, D.J.; Jordan, J.M.; Yelin, E.; Paltiel, A.D.; Katz, J.N. Journal: Osteoarthritis and cartilage Issue: Volume 24:Issue 5(2016) Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗